泰格医药：曹晓春已减持0.04%股份

Core Viewpoint - The major shareholder of Tiger Med, Ms. Cao Xiaochun, has completed her share reduction plan, selling a total of 347,600 shares, which represents 0.0406% of the company's total share capital after excluding repurchased shares [1] Summary by Sections - Shareholder Activity - Ms. Cao Xiaochun reduced her holdings by 347,600 shares during the designated reduction period [1] - Following the reduction, she holds 51,314,174 shares, accounting for 6.0007% of the total share capital [1] - Impact on Company Structure - The share reduction did not result in any change in the company's control [1] - The governance structure and ongoing operations of the company remain unaffected [1]